CD40 Agonist and PD-1 Inhibitor in HNSCC
Clinical trial NCT06159621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06159621
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2028-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.